STERIS plc
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of STERIS plc (STE). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2024 | 2025 | 2026 |
|---|---|---|---|
| Healthcare Segment | $3.61B 70.3% | $3.88B 71.0% · +7.4% | $4.21B 70.9% · +8.5% |
| AST | $954.0M 18.6% | $1.04B 19.0% · +8.9% | $1.14B 19.2% · +9.6% |
| Life Sciences | $571.7M 11.1% | $542.3M 9.9% · -5.1% | $588.8M 9.9% · +8.6% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Revenue by region
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| UNITED STATES | $2.23B 71.7% | $2.94B 69.7% · +32.2% | $3.25B 71.7% · +10.5% | $3.75B 73.0% · +15.3% | $4.01B 73.4% · +6.8% | $4.33B 73.0% · +8.1% |
| Other foreign locations [Member] | $808.6M 26.0% | $1.20B 28.4% · +48.1% | $1.21B 26.6% · +0.8% | $1.30B 25.4% · +8.0% | $1.34B 24.6% · +3.1% | $1.49B 25.2% · +11.1% |
| IRELAND | $71.9M 2.3% | $81.9M 1.9% · +13.9% | $74.3M 1.6% · -9.2% | $82.7M 1.6% · +11.3% | $107.3M 2.0% · +29.7% | $108.5M 1.8% · +1.1% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Revenue by product line
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Product [Member] | $1.44B 46.5% | $2.19B 52.0% · +52.0% | $2.36B 52.1% · +7.7% | $2.76B 53.8% · +16.9% | $2.87B 52.6% · +3.9% | $3.06B 51.6% · +6.6% |
| Service [Member] | $1.66B 53.5% | $2.03B 48.0% · +21.9% | $2.17B 47.9% · +7.1% | $2.37B 46.2% · +9.3% | $2.59B 47.4% · +9.0% | $2.88B 48.4% · +11.1% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 10, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.